DE60017201D1 - Rhodaminderivate für die photodynamische diagnose und behandlung - Google Patents

Rhodaminderivate für die photodynamische diagnose und behandlung

Info

Publication number
DE60017201D1
DE60017201D1 DE60017201T DE60017201T DE60017201D1 DE 60017201 D1 DE60017201 D1 DE 60017201D1 DE 60017201 T DE60017201 T DE 60017201T DE 60017201 T DE60017201 T DE 60017201T DE 60017201 D1 DE60017201 D1 DE 60017201D1
Authority
DE
Germany
Prior art keywords
treatment
rhodamine derivatives
derivatives
photodynamic diagnosis
photodynamic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60017201T
Other languages
English (en)
Other versions
DE60017201T2 (de
Inventor
Denis-Claude Roy
Martin Guimond
A Molfino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite de Montreal
Hopital Maisonneuve Rosemont
Original Assignee
Universite de Montreal
Hopital Maisonneuve Rosemont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite de Montreal, Hopital Maisonneuve Rosemont filed Critical Universite de Montreal
Publication of DE60017201D1 publication Critical patent/DE60017201D1/de
Application granted granted Critical
Publication of DE60017201T2 publication Critical patent/DE60017201T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0023—Agression treatment or altering
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
DE60017201T 1999-10-05 2000-10-03 Rhodaminderivate für die photodynamische diagnose und behandlung Expired - Lifetime DE60017201T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15779099P 1999-10-05 1999-10-05
US157790P 1999-10-05
PCT/CA2000/001142 WO2001024824A1 (en) 1999-10-05 2000-10-03 Rhodamine derivatives for photodynamic diagnosis and treatment

Publications (2)

Publication Number Publication Date
DE60017201D1 true DE60017201D1 (de) 2005-02-03
DE60017201T2 DE60017201T2 (de) 2005-12-29

Family

ID=22565296

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60017201T Expired - Lifetime DE60017201T2 (de) 1999-10-05 2000-10-03 Rhodaminderivate für die photodynamische diagnose und behandlung

Country Status (12)

Country Link
EP (1) EP1267931B1 (de)
JP (3) JP4859319B2 (de)
KR (1) KR100697400B1 (de)
AT (1) ATE285793T1 (de)
AU (1) AU781855B2 (de)
BR (1) BR0014135A (de)
CA (2) CA2382885C (de)
DE (1) DE60017201T2 (de)
ES (1) ES2234668T3 (de)
MX (1) MXPA02003522A (de)
PT (1) PT1267931E (de)
WO (1) WO2001024824A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8409564B2 (en) 1999-10-05 2013-04-02 Universite De Montreal Rhodamine derivatives for photodynamic diagnosis and treatment
MXPA02011638A (es) * 2001-04-02 2003-05-14 Celmed Biosciences Inc Derivados de rodamina halogenados y aplicaciones de los mismos.
CA2342675A1 (en) 2001-04-02 2002-10-02 Abdelkrim Habi Halogenated rhodamine derivatives and applications thereof
WO2003045979A2 (en) * 2001-11-29 2003-06-05 Therakos, Inc. Methods for pretreating a subject with extracorporeal photopheresis and/or apoptotic cells
CA2548468C (en) * 2003-12-05 2012-05-29 Universite De Montreal The use of dead cell material obtained from rhodamine-based photodynamic therapy in the treatment or prevention of immunologic disorders, infections and cancers
GB0912584D0 (en) * 2009-07-20 2009-08-26 Ucl Business Plc Cyclosporin conjugates
EP3058957A1 (de) 2015-02-19 2016-08-24 Kiadis Pharma Intellectual Property BV Verbessertes fotodynamisches Verfahren und daraus hergestelltes Produkt
RU2637279C2 (ru) * 2015-12-25 2017-12-01 Сергей Петрович Кречетов Способ фотодинамической терапии
TWI715927B (zh) * 2019-02-01 2021-01-11 國立清華大學 組合物用於製備治療癌細胞的藥物的用途
EP3730627A1 (de) 2019-04-25 2020-10-28 Kiadis Pharma Intellectual Property BV Verfahren zur überprüfung der spenderidentität
EP3769770A1 (de) 2019-07-23 2021-01-27 Kiadis Pharma Intellectual Property BV Verfahren zur hemmung oder prävention von infektionen bei einem transplantatempfänger
CN115960090B (zh) * 2022-12-30 2024-03-29 中山大学 一种罗丹明b修饰吡啶配体的制备方法及其光催化抗菌应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321919A (en) * 1979-12-11 1982-03-30 Leukocyte Research, Inc. Method and system for externally treating human blood
JP2811371B2 (ja) * 1991-06-21 1998-10-15 バクスター、インターナショナル、インコーポレイテッド 体液中の病原を不活性化する方法
US5807881A (en) * 1992-05-27 1998-09-15 Quadra Logic Technologies, Inc. Method for selectively reducing activated leukocyte cell population
US5556992A (en) * 1994-09-02 1996-09-17 Universite De Montreal Novel rhodamine derivatives for photodynamic therapy of cancer and in vitro purging of the leukemias
CA2250919C (en) * 1996-03-29 2008-05-13 Therakos, Inc. Photopheresis treatment of leukocytes
WO1998019677A1 (fr) * 1996-11-06 1998-05-14 Meiji Seika Kaisha, Ltd. Traitement de maladies auto-immunes par photochimiotherapie
EP1005531A2 (de) * 1997-07-21 2000-06-07 Cerus Corporation Verfahren zur verhandlung für leukozyten, leukozyten enthaltende zusammensetzungen und deren verwendungen
EP1010426A4 (de) * 1997-08-05 2004-06-30 Meiji Seika Kaisha Immunosuppresion durch photochemotherapie
JP2001525176A (ja) * 1997-12-04 2001-12-11 デューク・ユニバーシティー Ｃｄ７＋ｃｄ３４−ｌｉｎ−造血細胞を単離し、使用する方法

Also Published As

Publication number Publication date
KR20020050234A (ko) 2002-06-26
CA2382885A1 (en) 2001-04-12
KR100697400B1 (ko) 2007-03-20
AU7635700A (en) 2001-05-10
JP2003510372A (ja) 2003-03-18
ATE285793T1 (de) 2005-01-15
ES2234668T3 (es) 2005-07-01
WO2001024824A1 (en) 2001-04-12
MXPA02003522A (es) 2004-09-10
JP2011229537A (ja) 2011-11-17
PT1267931E (pt) 2005-05-31
CA2699662A1 (en) 2001-04-12
JP4859319B2 (ja) 2012-01-25
JP2011093939A (ja) 2011-05-12
EP1267931B1 (de) 2004-12-29
AU781855B2 (en) 2005-06-16
BR0014135A (pt) 2002-05-21
CA2382885C (en) 2010-06-29
JP5476342B2 (ja) 2014-04-23
EP1267931A1 (de) 2003-01-02
DE60017201T2 (de) 2005-12-29

Similar Documents

Publication Publication Date Title
ATE285793T1 (de) Rhodaminderivate für die photodynamische diagnose und behandlung
HUP0000576A2 (hu) A zöld porfirinek alkalmazása szekunder szürkehályogok kezelésére alkalmas gyógyszerek készítésében
SE9902163D0 (sv) Stable rotable radiation gantry
NO20075065L (no) Anvendelse av isoflavonforbindelser til a behandle hjertesykdom
DE69718053T2 (de) in vitro methoden und verwendung von pharmazeutische zusammensetzungen für die BEHANDLUNG VON INNENOHRHAARZELLEN
GR1000611B (el) Μεθοδος για την παρασκευη οφθαλμικων συνθεσεων κυκλοσπορινης.
DE69521620D1 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
ATE288431T1 (de) Substituierte bizyklische derivate für die behandlung von unnormalem zellwachstum
NZ529682A (en) Biologically active methylene blue derivatives
ATE250576T1 (de) Substituierte pyrrolylverbindungen zur behandlung von entzündungen
PA8447801A1 (es) Derivados del acido hexanoico
DE69927823D1 (de) Hydrogel für die therapeutische behandlung von aneurysmas
DE59611341D1 (de) Verwendung von saccharid-konjugaten
DE60022754D1 (de) Diagnose und behandlung von arrhythmien
NO20013004D0 (no) Anvendelse av biokjemiske substanser i en sammensetning for forhindringen og behandlingen av helsetilstander forårsaket avkonstriksjon av glattmuskelceller i organer i det menneskeligelegemet
TR200402628T4 (tr) Androjenetik ve yaygın alopezinin tedavisinde melatonin maddesinin kullanımı
DE60001555T2 (de) Wässrige lösung zum konservieren von gewebe und organen
BR0017163A (pt) Derivados 5-hidróxi-indazol para tratamento do glaucoma
CY1109233T1 (el) Προφυλακτικη και θεραπευτικη χρηση υδροξυστεροειδων
TR200101149T2 (tr) Dış retina bozukluklarının tedavisi.
DE69003937T2 (de) Mittel für die diagnose und die behandlung der melanomen, halogenierte, aromatische derivate, verwendbar als solche mittel und ihre herstellung.
MX9700959A (es) Derivados de becimidazol que tienen actividad dopaminergica.
WO2000061124A3 (en) Use off cell membrane penetrating indigoid bisindole derivatives
CY1106409T1 (el) Παραγωγα κινολινης
ATE364397T1 (de) Photosensibilisatoren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition